International Journal of Nursing Studies
Volume 46, Issue 5 , Pages 645-652 , May 2009

An evaluation of a medication management training programme for community mental health professionals; service user level outcomes: A cluster randomised controlled trial

  • Neil Harris

      Affiliations

    • Manchester Mental Health & Social Care Trust, University of Manchester, School of Nursing, Midwifery and Social Work, United Kingdom
    • Corresponding Author InformationCorresponding author.
    • ,
  • Karina Lovell

      Affiliations

    • Head of Mental Health Research, University of Manchester, School of Nursing, Midwifery and Social Work, United Kingdom
    • ,
  • Jennifer Day

      Affiliations

    • Advanced Mental Health, 5 Boroughs Partnership Trust, United Kingdom
    • ,
  • Christopher Roberts

      Affiliations

    • Medical Statistics, University of Manchester, Faculty of Medical and Human Sciences, United Kingdom

Received 10 June 2008 ,Revised 17 October 2008 ,Accepted 22 October 2008.

References 

  1. Baldessarini RJ, Viguera AC. Neuroleptic withdrawal in schizophrenic patients. Archives of General Psychiatry. 1995;52:189–192
  2. Birchwood M, Smith J, Cochrane R, Wetton S, Copestake S. The social functioning scale the development and validation of a scale of social adjustment for use in family intervention programmes with schizophrenic patients. British Journal of Psychiatry. 1990;157:853–859
  3. Bland J, Kerry S. Trials randomised in clusters. British Medical Journal. 1997;315:600
  4. Davison AC, Hinkley DV. Bootstrap Methods and Their Application. Cambridge University Press; 1997;
  5. Day JC, Bentall RP, Roberts C, Randall F, Rogers A, Cattell D, et al. Attitude toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Archives of General Psychiatry. 2005;62:717–724
  6. Day JC, Wood G, Dewey M, et al. A self-rating scale for measuring neuroleptic side-effects: validation in a group of schizophrenic patients. British Journal of Psychiatry. 1995;166:650–653
  7. Department of Health, 2005. Improving mental health services by extending the role of nurses by prescribing and supplying medication; a good practice guide Pub DoH.
  8. Department of Health, 2006. From values to action: the chief nursing officer's review of mental health nursing Pub DoH.
  9. Donner A, Klar . Design and Analysis of Cluster Randomisation Trial in Health Research. Arnold; 2000;
  10. Donner A, Birkett N, Buck C. Randomization by cluster: sample size requirements and analyses. American Journal of Epidemiology. 1981;114:906–913
  11. Gaston L., Marmar C., 1993. Manual of California Psychotherapy Alliance Scale.
  12. Gilbert PL, Harris MJ, McAdams LA, Jeste DV. Neuroleptic withdrawal in schizophrenic patients. Archives of General Psychiatry. 1995;95:173–188
  13. Grey R, Wykes T, Edmonds M, Leese M, Gournay K. Effect of a medication management training package for nurses on clinical outcomes for patients with schizophrenia. British Journal of Psychiatry. 2004;185:157–162
  14. Gray R, Leese M, Bindman J, et al. Adherence therapy for people with schizophrenia European multicentre randomised controlled trial. British Journal of Psychiatry. 2006;189:508–514
  15. Harris N, Lovell K, Day JC. Mental Health practitioners attitude towards maintenance neuroleptic treatment for people with schizophrenia. Journal of Psychiatric and Mental health Nursing. 2007;14:113–119
  16. Hogan TP, Awad AG. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychological Medicine. 1983;13:177–183
  17. Kemp R, Heywood P, David A. Compliance Therapy Manual. London Bethlem and Maudsley: NHS Trust; 1997;
  18. Kemp R, David A, Hayward P. Compliance therapy: an intervention targeting insight and treatment adherence in psychotic patients. Behavioural and Cognitive Psychotherapy. 1998;24:331–350
  19. Krawiecka M, Goldberg D, Vaughan M. A standardised psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatrica Scandinvica. 1977;55:299–308modified by S. Lancashire (1998)
  20. McIntosh, A.M., Conlon, L., Lawie, S.M., Stanfield, A.C., 2006. Compliance therapy for schizophrenia Cochrane Database of Systematic Reviews, 3.
  21. Randell F, Wood P, Day JC, Bentall R, Rogers A, Healy D. Enhancing appropriate adherence with neuroleptic medication: two contrasting approaches. In:  Morrison AP editors. A Case Book of Cognitive Therapy for Psychosis. Brunner-Routledge; 2003;
  22. Roberts C. The implications of variation in outcome between health professionals for the design and analysis of randomized controlled trials. Statistics in Medicine. 1999;18:2605–2615
  23. Robinson D, Woerner MG, Alvir JM, et al. Predictors of relapse following response from a first episode of schizophrenia or schizo-affective disorder. Archives of General Psychiatry. 1999;56:241–247
  24. Sainsbury Centre for Mental Health, 2001. The Capable Practitioner; A framework and list of the practitioner capabilities required to implement, The National Service Framework for Mental Health Pub Sainsbury Centre for Mental Health.
  25. Skingsley D, Bradley EJ, Nolan P. Neuropharmacology and mental health nurse prescribers. Journal of Clinical Nursing. 2006;15(8):989–997
  26. Stata Statistical Software Release 8.0. . Stata Statistical Software Release 8.0. Texas USA: Stata Corp College Station; 2002;
  27. Torgerson DJ. Contamination in trials: is cluster randomisation the answer?. British Medical Journal. 2001;322:355–357
  28. Ukoumunne OC, Gulliford MC, Chinn S, et al. Methods for evaluating area-wide and organisation-based interventions in health and health care: systematic review. Health Technology Assessment. 1999;3:5

PII: S0020-7489(08)00281-2

doi: 10.1016/j.ijnurstu.2008.10.010

International Journal of Nursing Studies
Volume 46, Issue 5 , Pages 645-652 , May 2009

Article Tools

* Image Usage & Resolution